Advertisement
Screener

iSpecimen Inc. (ISPC) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

iSpecimen Inc. Cash Flow Breakdown

Cash flow breakdown shows where iSpecimen Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $4.24M went out.
  • Fiscal year ended 2025-12-31: from investing, $1.00M went out.
  • Fiscal year ended 2025-12-31: from financing, $10.24M came in.
  • Fiscal year ended 2025-12-31: change in cash, $5.00M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew debtNew shares soldNot split outChange in cash
2025-12-31-$4.24M-$1.00M$4.00M$6.24M*$5.00M
2024-12-31-$8.26M$1.98M$398.44K$5.42M*-$465.26K
2023-12-31-$5.81M-$7.23M$70.89K-$12.97M
2022-12-31-$5.82M-$3.19M$78.64K-$3.50M*-$12.43M
2021-12-31-$10.67M-$1.04M$3.50M$2.50M$32.75M*$27.04M
2020-12-31-$288.38K-$1.10M$0.00$2.03M*$642.02K

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksNew debtNew shares soldNot split outChange in cash
2026-06-30-$689.63K*$0.00*
2026-03-31-$3.36M-$700.00K-$4.06M
2025-12-31-$916.92K*$0.00*$2.25M*$2.77M*
2025-09-30-$2.04M*-$1.00M*$1.75M*$3.48M*
2025-06-30-$192.23K*
2025-03-31-$1.10M-$1.10M
2024-12-31-$3.57M*-$73.06K*-$1.10M*$4.87M*
2024-09-30-$1.08M*-$179.95K*$0.00*$0.00*$859.98K*
2024-06-30-$1.54M*$295.12K*$0.00*$1.36M*
2024-03-31-$2.07M$1.94M-$52.50K$138.49K-$253.78K
2023-12-31$345.14K*-$723.04K*$0.00*
2023-09-30-$1.63M*$2.35M*$0.00*
2023-06-30-$1.69M*-$67.97K*$3.15K*
2023-03-31-$2.83M-$8.79M$67.74K-$11.55M
2022-12-31-$207.35K*-$1.64M*$254.00*-$3.50M*
2022-09-30-$2.26M*-$772.10K*$1.28K*
2022-06-30-$1.98M*-$438.02K*$1.83K*
2022-03-31-$1.38M-$339.16K$75.28K-$1.64M
2021-12-31-$1.32M*-$304.19K*$0.00*$0.00*$19.57M*
2021-09-30-$6.08M*-$290.84K*-$15.50M*$18.48M*
2021-06-30-$3.14M*-$228.35K*
2021-03-31-$126.25K-$214.53K-$340.78K
2020-12-31-$24.65K*-$236.69K*$0.00*
2020-09-30-$319.41K*-$273.90K*$0.00*

Similar stocks

Stock NameCountryMarket CapPE Ratio
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71
OneMedNet Corp (ONMD)$0.042B
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
NRC HEALTH (NRC)United States$0.450B42.50
OmniAb, Inc. (OABI)United States$0.698B-8.05
Absci Corp (ABSI)United States$1.775B-14.92
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14